Pfizer Inc (PFE)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | 14,909,000 | 10,129,000 | 1,580,000 | 1,970,000 | 3,793,000 | 11,818,000 | 25,510,000 | 36,188,000 | 40,492,000 | 38,103,000 | 34,149,000 | 26,509,000 | 20,525,000 | 14,292,000 | 11,147,000 | 9,293,000 | 8,759,000 | 12,934,000 | 12,929,000 | 13,627,000 |
| Total assets | US$ in thousands | 213,396,000 | 219,476,000 | 216,193,000 | 221,095,000 | 226,501,000 | 215,021,000 | 220,168,000 | 195,617,000 | 197,206,000 | 195,349,000 | 195,290,000 | 183,841,000 | 181,477,000 | 179,188,000 | 169,920,000 | 158,818,000 | 154,229,000 | 178,983,000 | 177,934,000 | 166,336,000 |
| Operating ROA | 6.99% | 4.62% | 0.73% | 0.89% | 1.67% | 5.50% | 11.59% | 18.50% | 20.53% | 19.51% | 17.49% | 14.42% | 11.31% | 7.98% | 6.56% | 5.85% | 5.68% | 7.23% | 7.27% | 8.19% |
December 31, 2024 calculation
Operating ROA = Operating income (ttm) ÷ Total assets
= $14,909,000K ÷ $213,396,000K
= 6.99%
Pfizer Inc's operating return on assets (ROA) fluctuated over the period from March 31, 2020, to December 31, 2024. The operating ROA started at 8.19% in March 2020 and gradually decreased to 5.68% by December 2020. However, there was a slight recovery in the following periods, with the operating ROA reaching 6.56% in June 2021 and 7.98% in September 2021.
A significant improvement was observed in the latter part of 2021, with the operating ROA surging to 11.31% by December 2021, and further increasing to 20.53% by December 2022, reaching the highest level during this period. However, the operating ROA started to decline thereafter, dropping to 1.67% by December 2023 and further decreasing to 0.73% by June 2024.
The operating ROA experienced some volatility in the subsequent quarters, showing a notable recovery to 6.99% by December 2024. Overall, Pfizer Inc's operating ROA displayed fluctuations, indicating changing profitability levels relative to its asset base during the period under review. It is essential to further analyze the company's operational efficiency and asset management strategies to understand the reasons behind these fluctuations in operating ROA.
Peer comparison
Dec 31, 2024